Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROaα and S100A8/A9

Oncology Reports

Volumn 34, Issue 6, 2015, Pages 2889-2900

  Hsu, Ya Ling ^a   Hung, Jen Yu ^b,c   Tsai, Eing Mei ^a   Wu, Cheng Ying ^a   Ho, Ya Wen ^a   Jian, Shu Fang ^a   Yen, Meng Chi ^c   Chang, Wei An ^a,c   Hou, Ming Feng ^a   Kuo, Po Lin ^a,d,e  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Breast cancer; Chemoresistance; Phthalate esters

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CXCL1 CHEMOKINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; NEUTRALIZING ANTIBODY; PHTHALIC ACID BENZYL BUTYL ESTER; CXCL1 PROTEIN, HUMAN; PHTHALIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EXPOSURE; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SUPPRESSOR CELL; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ANIMAL; BIOSYNTHESIS; BREAST NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; GENETICS; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, NEUTRALIZING; BREAST NEOPLASMS; CALGRANULIN A; CALGRANULIN B; CELL LINE, TUMOR; CHEMOKINE CXCL1; CYCLOPHOSPHAMIDE; DENDRITIC CELLS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICE; PHTHALIC ACIDS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84943788218     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4307     Document Type: Article

References (44)

1. Cirillo T, Fasano E, Castaldi E, Montuori P and Amodio Cocchieri R: Children's exposure to Di(2-ethylhexyl) phthalate and dibutylphthalate plasticizers from school meals. J Agric Food Chem 59: 10532-10538, 2011.
2. Casajuana N and Lacorte S: New methodology for the determination of phthalate esters, bisphenol A, bisphenol A diglycidyl ether, and nonylphenol in commercial whole milk samples. J Agric Food Chem 52: 3702-3707, 2004.
3. Wu Z, Zhang X, Wu X, Shen G, Du Q and Mo C: Uptake of di(2-ethylhexyl) phthalate (DEHP) by the plant Benincasa hispida and its use for lowering DEHP content of intercropped vegetables. J Agric Food Chem 61: 5220-5225, 2013.
4. Liu Y, Wang S and Wang L: Development of rapid determination of 18 phthalate esters in edible vegetable oils by gas chromatography tandem mass spectrometry. J Agric Food Chem 61: 1160-1164, 2013.
5. Yan H, Cheng X and Yang G: Dummy molecularly imprinted solid-phase extraction for selective determination of five phthalate esters in plastic bottled functional beverages. J Agric Food Chem 60: 5524-5531, 2012.
6. Sun H, Yang Y, Li H, Zhang J and Sun N: Development of multiresidue analysis for twenty phthalate esters in edible vegetable oils by microwave-assisted extraction-gel permeation chromatography-solid phase extraction-gas chromatography-tandem mass spectrometry. J Agric Food Chem 60: 5532-5539, 2012.
7. Fu X and Du Q: Uptake of di-(2-ethylhexyl) phthalate of vegetables from plastic film greenhouses. J Agric Food Chem 59: 11585-11588, 2011.
8. Guo Y, Zhang Z, Liu L, Li Y, Ren N and Kannan K: Occurrence and profiles of phthalates in foodstuffs from China and their implications for human exposure. J Agric Food Chem 60: 6913-6919, 2012.
9. Cirillo T, Latini G, Castaldi MA, Dipaola L, Fasano E, Esposito F, Scognamiglio G, Francesco FD and Cobellis L: Exposure to di-2-ethylhexyl phthalate, di-n-butyl phthalate and bisphenol A through infant formulas. J Agric Food Chem 63: 3303-3310, 2015.
10. Gaspar FW, Castorina R, Maddalena RL, Nishioka MG, McKone TE and Bradman A: Phthalate exposure and risk assessment in California child care facilities. Environ Sci Technol 48: 7593-7601, 2014.
11. Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Lee JN, Chai CY, Wang SC and Tsai EM: Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway. FASEB J 26: 778-787, 2012.
12. Carran M and Shaw IC: New Zealand Malayan war veterans' exposure to dibutylphthalate is associated with an increased incidence of cryptorchidism, hypospadias and breast cancer in their children. NZ Med J 125: 52-63, 2012.
13. Fernandez SV and Russo J: Estrogen and xenoestrogens in breast cancer. Toxicol Pathol 38: 110-122, 2010.
14. Chen FP and Chien MH: Lower concentrations of phthalates induce proliferation in human breast cancer cells. Climacteric 17: 377-384, 2014.
15. Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Hsi E, Suen JL, Hung CH, Lee JN, Chai CY, Wang SC, et al: n-Butyl benzyl phthalate promotes breast cancer progression by inducing expression of lymphoid enhancer factor 1. PLoS One 7: e42750, 2012.
16. Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Lee JN, Chai CY, Hou MF, Chang CC, Long CY, Ko YC, et al: Phthalates stimulate the epithelial to mesenchymal transition through an HDAC6-dependent mechanism in human breast epithelial stem cells. Toxicol Sci 128: 365-376, 2012.
17. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin 65: 87-108, 2015.
18. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136: E359-E386, 2015.
19. Roché H and Vahdat LT: Treatment of metastatic breast cancer: Second line and beyond. Ann Oncol 22: 1000-1010, 2011.
20. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, Li F, Reiss M, Au JL, Haffty BG and Kang Y: MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 15: 9-20, 2009.
21. Klemm F and Joyce JA: Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol 25: 198-213, 2015.
22. Grivennikov SI, Greten FR and Karin M: Immunity, inflammation, and cancer. Cell 140: 883-899, 2010.
23. Weizman N, Krelin Y, Shabtay-Orbach A, Amit M, Binenbaum Y, Wong RJ and Gil Z: Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase. Oncogene 33: 3812-3819, 2014.
24. Mitchem JB, Brennan DJ, Knolhoff BL, Belt BA, Zhu Y, Sanford DE, Belaygorod L, Carpenter D, Collins L, Piwnica-Worms D, et al: Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res 73: 1128-1141, 2013.
25. Hsu YL, Hung JY, Tsai YM, Tsai EM, Huang MS, Hou MF and Kuo PL: 6-shogaol, an active constituent of dietary ginger, impairs cancer development and lung metastasis by inhibiting the secretion of CC-chemokine ligand 2 (CCL2) in tumor-associated dendritic cells. J Agric Food Chem 63: 1730-1738, 2015.
26. Kan JY, Wu DC, Yu FJ, Wu CY, Ho YW, Chiu YJ, Jian SF, Hung JY, Wang JY and Kuo PL: Chemokine (C-C motif) ligand 5 is involved in tumor-associated dendritic cell-mediated colon cancer progression through non-coding RNA MALAT-1. J Cell Physiol 230: 1883-1894, 2015.
27. Kuo PL, Huang MS, Cheng DE, Hung JY, Yang CJ and Chou SH: Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor. J Biol Chem 287: 9753-9764, 2012.
28. Tang XH, Deng S, Li M and Lu MS: The anti-tumor effect of cross-reacting material 197, an inhibitor of heparin-binding EGF-like growth factor, in human resistant ovarian cancer. Biochem Biophys Res Commun 422: 676-680, 2012.
29. Qian DZ, Rademacher BL, Pittsenbarger J, Huang CY, Myrthue A, Higano CS, Garzotto M, Nelson PS and Beer TM: CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity. Prostate 70: 433-442, 2010.
30. Lee E, Lee SJ, Koskimaki JE, Han Z, Pandey NB and Popel AS: Inhibition of breast cancer growth and metastasis by a biomimetic peptide. Sci Rep 4: 7139, 2014.
31. Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, Manova-Todorova K, Leversha M, Hogg N, Seshan VE, et al: A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 150: 165-178, 2012.
32. Wang L, Chang EWY, Wong SC, Ong SM, Chong DQY and Ling KL: Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol 190: 794-804, 2013.
33. Miyake M, Goodison S, Urquidi V, Gomes Giacoia E and Rosser CJ: Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways. Lab Invest 93: 768-778, 2013.
34. Palucka K, Coussens LM and O'Shaughnessy J: Dendritic cells, inflammation, and breast cancer. Cancer J 19: 511-516, 2013.
35. Coussens LM, Zitvogel L and Palucka AK: Neutralizing tumor-promoting chronic inflammation: A magic bullet? Science 339: 286-291, 2013.
36. Hartmann TN, Burger JA, Glodek A, Fujii N and Burger M: CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene 24: 4462-4471, 2005.
37. Angst E, Reber HA, Hines OJ and Eibl G: Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2. Surgery 144: 57-65, 2008.
38. Chen R, Alvero AB, Silasi DA and Mor G: Inflammation, cancer and chemoresistance: Taking advantage of the toll-like receptor signaling pathway. Am J Reprod Immunol 57: 93-107, 2007.
39. Srikrishna G: S100A8 and S100A9: New insights into their roles in malignancy. J Innate Immun 4: 31-40, 2012.
40. Ichikawa M, Williams R, Wang L, Vogl T and Srikrishna G: S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res 9: 133-148, 2011.
41. Yang M, Zeng P, Kang R, Yu Y, Yang L, Tang D and Cao L: S100A8 contributes to drug resistance by promoting autophagy in leukemia cells. PLoS One 9: e97242, 2014.
42. Zou A, Lambert D, Yeh H, Yasukawa K, Behbod F, Fan F and Cheng N: Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins. BMC Cancer 14: 781, 2014.
43. Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, Wu S, Han HD, Shah MY, Rodriguez-Aguayo C, et al: Tumour angiogenesis regulation by the miR-200 family. Nat Commun 4: 2427, 2013.
44. Nishioka J, Iwahara C, Kawasaki M, Yoshizaki F, Nakayama H, Takamori K, Ogawa H and Iwabuchi K: Di-(2-ethylhexyl) phthalate induces production of inflammatory molecules in human macrophages. Inflamm Res 61: 69-78, 2012.